[Intra-arterial infusion chemotherapy in combination with angiotensin II in advanced bladder cancer]. 1986

T Akagi, and Y Matsumura, and Y Ozaki, and T Tsushima, and T Obama, and Y Nasu, and H Ohmori, and N Mitsuhata

Intra-arterial infusion chemotherapy in combination with angiotensin II was performed in 5 patients with advanced bladder cancer (all T3M0). The infusion catheter was inserted from a femoral artery into the internal iliac artery. The basic dosage was 70 mg/m2 of Cis-diammine-dichloroplatinum (CDDP) and 40 mg/m2 of Adriamycin (ADM) or 4'-0-tetrahydropyranyl-ADM (THP) in combination with 20-40 micrograms angiotensin II over a total duration of 20 minutes for both sides. Of the 5 patients, 3 CR and 2 PR were obtained by only one or two courses of intra-arterial infusion chemotherapy. Histological examination showed no viable cells in the three CR cases. Intra-arterial infusion chemotherapy in combination with angiotensin II may thus be clinically useful for advanced bladder cancer.

UI MeSH Term Description Entries
D007261 Infusions, Intra-Arterial Regional infusion of drugs via an arterial catheter. Often a pump is used to impel the drug through the catheter. Used in therapy of cancer, upper gastrointestinal hemorrhage, infection, and peripheral vascular disease. Infusions, Regional Arterial,Infusions, Intra Arterial,Infusions, Intraarterial,Arterial Infusion, Intra,Arterial Infusion, Regional,Arterial Infusions, Intra,Arterial Infusions, Regional,Infusion, Intra Arterial,Infusion, Intra-Arterial,Infusion, Intraarterial,Infusion, Regional Arterial,Intra Arterial Infusion,Intra Arterial Infusions,Intra-Arterial Infusion,Intra-Arterial Infusions,Intraarterial Infusion,Intraarterial Infusions,Regional Arterial Infusion,Regional Arterial Infusions
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Akagi, and Y Matsumura, and Y Ozaki, and T Tsushima, and T Obama, and Y Nasu, and H Ohmori, and N Mitsuhata
September 1986, The Journal of urology,
T Akagi, and Y Matsumura, and Y Ozaki, and T Tsushima, and T Obama, and Y Nasu, and H Ohmori, and N Mitsuhata
October 1989, Gan to kagaku ryoho. Cancer & chemotherapy,
T Akagi, and Y Matsumura, and Y Ozaki, and T Tsushima, and T Obama, and Y Nasu, and H Ohmori, and N Mitsuhata
August 1992, Gan to kagaku ryoho. Cancer & chemotherapy,
T Akagi, and Y Matsumura, and Y Ozaki, and T Tsushima, and T Obama, and Y Nasu, and H Ohmori, and N Mitsuhata
April 1985, Nihon Gan Chiryo Gakkai shi,
T Akagi, and Y Matsumura, and Y Ozaki, and T Tsushima, and T Obama, and Y Nasu, and H Ohmori, and N Mitsuhata
August 1990, Gan to kagaku ryoho. Cancer & chemotherapy,
T Akagi, and Y Matsumura, and Y Ozaki, and T Tsushima, and T Obama, and Y Nasu, and H Ohmori, and N Mitsuhata
January 1983, Cancer chemotherapy and pharmacology,
T Akagi, and Y Matsumura, and Y Ozaki, and T Tsushima, and T Obama, and Y Nasu, and H Ohmori, and N Mitsuhata
January 1992, Cancer chemotherapy and pharmacology,
T Akagi, and Y Matsumura, and Y Ozaki, and T Tsushima, and T Obama, and Y Nasu, and H Ohmori, and N Mitsuhata
August 1988, Tumori,
T Akagi, and Y Matsumura, and Y Ozaki, and T Tsushima, and T Obama, and Y Nasu, and H Ohmori, and N Mitsuhata
September 1999, Hinyokika kiyo. Acta urologica Japonica,
T Akagi, and Y Matsumura, and Y Ozaki, and T Tsushima, and T Obama, and Y Nasu, and H Ohmori, and N Mitsuhata
August 1987, Hinyokika kiyo. Acta urologica Japonica,
Copied contents to your clipboard!